Dominik Arnold to become new CEO of the COLTENE Group
September 08, 2023 at 12:02 am EDT
Share
COLTENE Holding AG / Key word(s): Personnel
Dominik Arnold to become new CEO of the COLTENE Group
08-Sep-2023 / 06:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
The Board of Directors of the COLTENE group, a leading international developer and manufacturer of dental consumables and small equipment, has appointed Dominik Arnold (51) to become the new CEO of the COLTENE group as of 1 January 2024. Dominik Arnold succeeds Martin Schaufelberger (59) who will step down from operations at the end of the year.
Dominik Arnold is CEO of Belimed AG, a leading provider of product and service solutions for sterilization, disinfection, and cleaning of medical and surgical instruments. He joined Belimed in 2019 and has notably grown the service business profitably, driven digitalization and made operations more efficient. Previously, he spent 20 years with various companies, in particular US-based Danaher, where he gained extensive knowledge in the life science and medtech industries and implemented international growth strategies. Arnold was able to gain extensive international experience through several years in Singapore and the USA. He holds a bachelor degree in biotechnology from the University of Applied Sciences Zurich and a master's degree in business management.
"COLTENE is well positioned internationally and offers a comprehensive product range for the three dental workflows infection control, restoration and endodontics," says President of the Board of Directors Nick Huber. "In Dominik Arnold, we have found an excellent successor to Martin Schaufelberger. He is an entrepreneurial leader with in-depth knowledge of the global medical sector. On behalf of the Board of Directors, I would like to thank Martin Schaufelberger, who has played a key role in shaping COLTENE over the past 11 years as CEO and has given the company a forward-looking orientation. During his tenure, he has improved results by optimizing processes, expanded the distribution network with various branches, and realized a new building at the headquarters in Altstätten. The merger with Micro-Mega and SciCan in 2018 helped the group to take a big step forward in growth."
In the first months of 2024, Martin Schaufelberger will assist his successor and will be available for consultation if needed. The Board of Directors proposes to appoint Martin Schaufelberger to the Board of Directors at the 2025 Annual General Meeting to ensure continuity in the cooperation with all stakeholders.
Dominik Arnold says: "I am looking forward to further develop the first-class offerings for our stakeholders together with the strong crew at COLTENE, and with customers and distributors. I am convinced that we can expand our collaboration and shape the dental market together. I look forward to interacting with the Board of Directors and my new colleagues in the global COLTENE family."
Martin Schaufelberger comments on the succession solution as follows: "I feel privileged to be part of the COLTENE success story. After eleven years, it is time for a staff handover and retirement from operational activities. I thank the Board of Directors for their trust."
For further information: Markus Abderhalden, CFO,
Phone +41 71 757 54 80, Mobile +41 79 436 26 22, E-Mail markus.abderhalden@coltene.com
Sign up for email updates from COLTENE Holding AG at www.coltene.com.
Financial Calendar
Release of Annual Report and
media and analyst conference on 2023 financial year
8 March 2024
Annual General Meeting 2024
17 April 2024
Release of Half-Year Report and
media and analyst conference on 2024 half-year results
8 August 2024
About COLTENE
COLTENE is an international developer, manufacturer, and seller of dental consumables and small equipment in the areas of Infection Control, Dental Preservation, and Efficient Treatment. COLTENE has state-of-the-art production facilities in the USA, Canada, Germany, France, and Switzerland as well as own sales organizations in all major markets including Europe, North and Latin America, Japan, China, and India. Dentists, DSOs, dental clinics, and dental labs all around the globe trust COLTENE's high-quality products. The registered shares of COLTENE Holding AG (CLTN) are listed on SIX Swiss Exchange. Learn more about COLTENE and our products at www.coltene.com.
Contact
COLTENE Holding AG
Feldwiesenstrasse 20
9450 Altstätten, Switzerland
P + 41 71 757 53 00 investor@coltene.com www.coltene.com
This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial conditions. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Coltene Holding AG is a Switzerland-based Company active in the healthcare sector. It develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. It has production facilities in Switzerland, the United States, Germany and Hungary. The Company's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.
COLTENE HOLDING AG 
